全球知识产权每日洞察 — 2026-06-16

Context:

Harbour Antibodies, a Dutch subsidiary of China’s Harbour BioMed, develops so-called Harbour Mice to create antibodies for the research, development, and production of biologic drugs. In December 23, 2021, Harbour Antibodies, Erasmus University Medical Center Rotterdam, and Dr. Roger Kingdon Craig sued Teneobio (a clinical-stage biotech company bought by Amgen in late 2021:

October 19, 2021 Amgen press release

) in the United States District Court for the District of Delaware over the alleged infringement of four patents:

U.S. Patent No. 9,346,877

Context:

Malikie Innovations holds a substantial portfolio of patents—including standard-essential patents (SEPs)—acquired from Blackberry, a number of which it has recently asserted in the United States against automakers Hyundai and Honda (

May 12, 2026

ip fray

article

Context:

Recent months have seen several big changes at patent pool operator Via Licensing Alliance, including the appointment of Kevin Mack as the company’s new President (

April 1, 2026

ip fray

article

Context:

FRAND (fair, reasonable and non discriminatory) disputes increasingly involve competing valuation methodologies, with courts and tribunals across jurisdictions relying on approaches such as comparable licenses, top-down analysis, and various forms of value-based valuation, often reaching different outcomes.

The World Intellectual Property Organization (WIPO) offers alternative dispute resolution (ADR) for standard-essential patent (SEP) matters. It also takes high-level positions on select patent policy topics.

What’s new:

WIPO recently published

Context:

Centripetal Networks and Cisco have been involved in long-running patent litigation over network-security technology since February 2018. In 2020, the United States District Court for the Eastern District of Virginia awarded Centripetal more than $1.9 billion after finding that Cisco infringed several patents, but the Federal Circuit later vacated that judgment. The patents associated with that dispute subsequently faced multiple United States Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB) challenges.

U.S. Patent No. 9,917,856

(“rule-based network-threat detection for encrypted communications”) was the last remaining patent at issue in the group of related reviews. In October 2025, the Federal Circuit remanded this particular inter partes review (IPR), directing the PTAB to reconsider evidence relating to alleged copying by Cisco.

To Read The Full Story